158 related articles for article (PubMed ID: 32991311)
21. ABCB4 disease: Many faces of one gene deficiency.
Sticova E; Jirsa M
Ann Hepatol; 2020; 19(2):126-133. PubMed ID: 31759867
[TBL] [Abstract][Full Text] [Related]
22. PNPLA3 rs738409 polymorphism is associated with liver fibrosis progression in patients with chronic hepatitis C: A repeated measures study.
Jiménez-Sousa MÁ; Gómez-Moreno AZ; Pineda-Tenor D; Sánchez-Ruano JJ; Fernández-Rodríguez A; Artaza-Varasa T; Gómez-Sanz A; Martín-Vicente M; Vázquez-Morón S; Resino S
J Clin Virol; 2018 Jun; 103():71-74. PubMed ID: 29674183
[TBL] [Abstract][Full Text] [Related]
23. PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis.
Chen LZ; Xin YN; Geng N; Jiang M; Zhang DD; Xuan SY
World J Gastroenterol; 2015 Jan; 21(3):794-802. PubMed ID: 25624712
[TBL] [Abstract][Full Text] [Related]
24. Outreach screening of drug users for cirrhosis with transient elastography.
Moessner BK; Jørgensen TR; Skamling M; Vyberg M; Junker P; Pedersen C; Christensen PB
Addiction; 2011 May; 106(5):970-6. PubMed ID: 21182552
[TBL] [Abstract][Full Text] [Related]
25. Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women.
Cherubini A; Ostadreza M; Jamialahmadi O; Pelusi S; Rrapaj E; Casirati E; Passignani G; Norouziesfahani M; Sinopoli E; Baselli G; Meda C; Dongiovanni P; Dondossola D; Youngson N; Tourna A; Chokshi S; Bugianesi E; ; Della Torre S; Prati D; Romeo S; Valenti L
Nat Med; 2023 Oct; 29(10):2643-2655. PubMed ID: 37749332
[TBL] [Abstract][Full Text] [Related]
26. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.
Gonzalez FA; Van den Eynde E; Perez-Hoyos S; Navarro J; Curran A; Burgos J; Falcó V; Ocaña I; Ribera E; Crespo M
HIV Med; 2015 Apr; 16(4):211-8. PubMed ID: 25234826
[TBL] [Abstract][Full Text] [Related]
27. Utility and accuracy of transient elastography in determining liver fibrosis: a case-control study.
Jain V; Poddar U; Negi TS; Saraswat VA; Krishnani N; Yachha SK; Srivastava A
Eur J Pediatr; 2020 Apr; 179(4):671-677. PubMed ID: 31960149
[TBL] [Abstract][Full Text] [Related]
28. Reversal of advanced fibrosis after long-term ursodeoxycholic acid therapy in a patient with residual expression of MDR3.
Frider B; Castillo A; Gordo-Gilart R; Bruno A; Amante M; Alvarez L; Mathet V
Ann Hepatol; 2015; 14(5):745-51. PubMed ID: 26256905
[TBL] [Abstract][Full Text] [Related]
29. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.
Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O
Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304
[TBL] [Abstract][Full Text] [Related]
30. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C.
Manchiero C; Nunes AKDS; Magri MC; Dantas BP; Mazza CC; Barone AA; Tengan FM
BMC Infect Dis; 2017 Dec; 17(1):780. PubMed ID: 29258449
[TBL] [Abstract][Full Text] [Related]
31. ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
Reichert MC; Lammert F
Semin Liver Dis; 2018 Nov; 38(4):299-307. PubMed ID: 30357767
[TBL] [Abstract][Full Text] [Related]
32. Non-invasive diagnosis of cirrhosis and long-term disease monitoring by transient elastography in patients with Wilson disease.
Paternostro R; Pfeiffenberger J; Ferenci P; Stättermayer AF; Stauber RE; Wrba F; Longerich T; Lackner K; Trauner M; Ferlitsch A; Reiberger T; Weiss KH
Liver Int; 2020 Apr; 40(4):894-904. PubMed ID: 31898387
[TBL] [Abstract][Full Text] [Related]
33. PNPLA3 is the dominant SNP linked to liver disease severity at time of first referral to a tertiary center.
Balcar L; Semmler G; Oberkofler H; Zandanell S; Strasser M; Datz L; Niederseer D; Feldman A; Stickel F; Datz C; Paulweber B; Aigner E
Dig Liver Dis; 2022 Jan; 54(1):84-90. PubMed ID: 34261618
[TBL] [Abstract][Full Text] [Related]
34. Primary liver injury and delayed resolution of liver stiffness after alcohol detoxification in heavy drinkers with the
Rausch V; Peccerella T; Lackner C; Yagmur E; Seitz HK; Longerich T; Mueller S
World J Hepatol; 2016 Dec; 8(35):1547-1556. PubMed ID: 28050235
[TBL] [Abstract][Full Text] [Related]
35. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.
Mazo DF; Malta FM; Stefano JT; Salles APM; Gomes-Gouvea MS; Nastri ACS; Almeida JR; Pinho JRR; Carrilho FJ; Oliveira CP
Ann Hepatol; 2019; 18(3):466-471. PubMed ID: 31054980
[TBL] [Abstract][Full Text] [Related]
36. Magnitude dependent discordance in liver stiffness measurements using elastography point quantification with transient elastography as the reference test.
Grgurevic I; Salkic N; Bozin T; Mustapic S; Matic V; Dumic-Cule I; Tjesic Drinkovic I; Bokun T
Eur Radiol; 2019 May; 29(5):2448-2456. PubMed ID: 30488108
[TBL] [Abstract][Full Text] [Related]
37. ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice.
Fan W; Liu T; Chen W; Hammad S; Longerich T; Hausser I; Fu Y; Li N; He Y; Liu C; Zhang Y; Lian Q; Zhao X; Yan C; Li L; Yi C; Ling Z; Ma L; Zhao X; Xu H; Wang P; Cong M; You H; Liu Z; Wang Y; Chen J; Li D; Hui L; Dooley S; Hou J; Jia J; Sun B
Gastroenterology; 2019 Nov; 157(5):1352-1367.e13. PubMed ID: 31362006
[TBL] [Abstract][Full Text] [Related]
38. The wide phenotypic and genetic spectrum of ABCB4 gene deficiency: A case series.
Falcão D; Pedroto I; Moreira T
Dig Liver Dis; 2022 Feb; 54(2):221-227. PubMed ID: 34376370
[TBL] [Abstract][Full Text] [Related]
39. Association of fetuin B with markers of liver fibrosis in nonalcoholic fatty liver disease.
Ebert T; Linder N; Schaudinn A; Busse H; Berger J; Lichtinghagen R; Keim V; Wiegand J; Karlas T
Endocrine; 2017 Nov; 58(2):246-252. PubMed ID: 28914407
[TBL] [Abstract][Full Text] [Related]
40. Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection.
Huang CF; Dai CY; Yeh ML; Huang CI; Tai CM; Hsieh MH; Liang PC; Lin YH; Hsieh MY; Yang HL; Huang JF; Lin ZY; Chen SC; Yu ML; Chuang WL
J Hepatol; 2015 Mar; 62(3):512-8. PubMed ID: 25457210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]